Production of recombinant protein in mammalian cells is time-consuming, labor-intensive and costly. While seeking to overcome these limitations, we discovered that Vaccinia virus has the innate ability to transfer exogenous plasmid DNA into mammalian cells during the infection process. Parameters influencing the efficiency of this event were characterized and a quick, simple and inexpensive way to produce eukaryotic proteins was established
The emergence of recombinant DNA technology during the early 70's set a revolution in molecular biol...
[[abstract]]©2004 Wiley - Although baculovirus-mediated gene delivery into mammalian cells has been ...
Faculty mentor: Dr. Nikunj SomiaThis research was supported by the Undergraduate Research Opportunit...
Abstract Background: The production of full length, biologically active proteins in mammalian cells ...
Recombinant DNA techniques have been used to engineer a DNA vaccine from a gene derived from Burkhol...
Vaccinia virus expression systems allow efficient expression of genes and facilitate functional stud...
Recombinant DNA techniques have been used to engineer a DNA vaccine from a gene derived from Burkhol...
The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicke...
Vaccinia virus (VACV) is an established vector for vaccination and is beginning to prove effective a...
The vaccinia virus expression system was developed into a scaleable recombinant protein production p...
Vaccinia virus (VACV) is an established vector for vaccination and is beginning to prove effective a...
Many applications in biotechnology require human proteins generated from human cells. Stable cell li...
We previously found that plasmids bearing a mammalian replication initiation region (IR) and a nucle...
Proteins are often produced using microbial cell factories for academic or industrial purposes. Prot...
AbstractModified vaccinia virus Ankara (MVA), a host range restricted and highly attenuated vaccinia...
The emergence of recombinant DNA technology during the early 70's set a revolution in molecular biol...
[[abstract]]©2004 Wiley - Although baculovirus-mediated gene delivery into mammalian cells has been ...
Faculty mentor: Dr. Nikunj SomiaThis research was supported by the Undergraduate Research Opportunit...
Abstract Background: The production of full length, biologically active proteins in mammalian cells ...
Recombinant DNA techniques have been used to engineer a DNA vaccine from a gene derived from Burkhol...
Vaccinia virus expression systems allow efficient expression of genes and facilitate functional stud...
Recombinant DNA techniques have been used to engineer a DNA vaccine from a gene derived from Burkhol...
The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicke...
Vaccinia virus (VACV) is an established vector for vaccination and is beginning to prove effective a...
The vaccinia virus expression system was developed into a scaleable recombinant protein production p...
Vaccinia virus (VACV) is an established vector for vaccination and is beginning to prove effective a...
Many applications in biotechnology require human proteins generated from human cells. Stable cell li...
We previously found that plasmids bearing a mammalian replication initiation region (IR) and a nucle...
Proteins are often produced using microbial cell factories for academic or industrial purposes. Prot...
AbstractModified vaccinia virus Ankara (MVA), a host range restricted and highly attenuated vaccinia...
The emergence of recombinant DNA technology during the early 70's set a revolution in molecular biol...
[[abstract]]©2004 Wiley - Although baculovirus-mediated gene delivery into mammalian cells has been ...
Faculty mentor: Dr. Nikunj SomiaThis research was supported by the Undergraduate Research Opportunit...